Background: Metabolic dysfunction–associated fatty liver disease (MAFLD) is strongly associated with obesity and metabolic dysfunction. Visceral adiposity plays a central role in disease progression from steatosis to fibrosis. Bioimpedance analysis (BIA) offers a simple and non-invasive method for evaluating body composition.
Zohidjon Asqarali ugli Umarov (Mon,) studied this question.